In The News

In The News

Alzforum | April 20, 2017
Tau pathology is linked with neurodegeneration in multiple tauopathies, and efforts are underway to vanquish this tangle-forming protein with anti-tau antibodies.
GenomeWeb| July 18, 2017
NEW YORK (GenomeWeb) – A team of investigators from Quanterix, Destina Genomics, and the University of Edinburgh have developed a new approach for the amplification-free detection of microRNA-122, a biomarker used for diagnosing liver toxicity.
CLP Magazine | September 26, 2017
Quanterix Corp, Lexington, Mass, is expanding its single molecule array, or Simoa, portfolio to include the new Quanterix SR-Plex benchtop instrument.
PharmaVOICE
Enjoyed discussing the future of  cancer care and the role biomarkers will play in advancing less invasive detection options, more accurate diagnoses and more personalized treatment pathways with PharmaVOICE.
Wyss Institute
December 5, 2018 Project combines highly sensitive biomarker discovery with human stem cell technology to develop a much needed blood diagnostic assay for Parkinson’s disease By Benjamin Boettner